Clari
ClariTrial
Built by Johnny Rice
Search
Explore
Companies
Targets
Safety
Pipeline
Competitive
Emerging
Map
Parsing your search query…
Explore
/
PD-1 PD-L1 checkpoint inhibitor CAR-T cancer immunotherapy
Search
Status
Recruiting
Active
Not Yet
Completed
Terminated
Phase
Early Ph 1
Phase 1
Phase 2
Phase 3
Phase 4
N/A
2
results for
“PD-1 PD-L1 checkpoint inhibitor CAR-T cancer immunotherapy”
NCT05871684
UNKNOWN
A Combination Study of CAR-T Therapy in r/r B-NHL
Phase 2
Diffuse Large B Cell Lymphoma
BTK inhibitor
PD-1 inhibitor
Ruijin Hospital
48 participants
1 site · China
Completes May 2024
More detail
Compare
CT.gov
Full analysis →
NCT07307053
Not Yet Recruiting
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
Phase 1
Phase 2
Rare Malignant Neoplasm
Advanced Solid Tumors
Metastatic Solid Tumors
BL-B01D1
VSV injection
CVL006
+17 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
600 participants
Completes Jan 2029
More detail
Compare
CT.gov
Full analysis →
Previous
1–2 of 2
Next